News

The sufentanil patch, which is in early-stage clinical development, employs Durect’s proprietary Transdur drug-adhesive matrix formulation and is intended to provide relief of moderate-to-severe chronic pain for up

The results of the three-month pilot confirm that radio-frequency identification (RFID) tags and printed barcodes can be mass-deployed and that pharmacists are keen to gain the advantages of

These findings, published in The Journal of Clinical Endocrinology & Metabolism, demonstrate the important role growth hormone (GH) treatment may play in reducing serious metabolic conditions, such as

Ecole Polytechnique Federale de Lausanne (EPFL) scientists used RNA interference in transgenic mice to silence a mutated gene that causes inherited cases of amytrophic lateral sclerosis (ALS, or

Researchers led by Dr Mira Edgerton, discovered that histatin binds to a specific membrane protein called TRK1p, which regulates potassium ion flow through the cell membrane of the

Sepracor’s Xopenex (levalbuterol tartrate) metered-dose inhaler (MDI) utilizes state-of-the-art HFA technology and does not contain a CFC propellant. Sepracor and 3M’s drug delivery systems division are collaborating under

The trial, named AX-CL-06a, is designed to evaluate the effects of Phenserine tartrate (PT) on cerebrospinal fluid (CSF) levels of beta-amyloid (A(beta) 1- 42) and other biomarkers in

Baraclude (entecavir) is an investigational oral antiviral agent that selectively inhibits the hepatitis B virus. Bristol-Myers Squibb submitted a new drug application (NDA) to the FDA for Baraclude

Sanofi-Aventis learned through the Canadian Ministry of Health website that Novopharm has obtained marketing approval in Canada for a product claiming to be generic enoxaparin. Sanofi-Aventis companies Aventis